Aprotinin therapy to reduce blood loss in Jehovah’s Witnesses

[The Librarian]

Canadian Journal of Anaesthesia

January 1994, Volume 41, Issue 1, pp 77–78

Aprotinin therapy to reduce blood loss in Jehovah’s Witnesses

• Authors
• Authors and affiliations

•  
•  
•  
•  
•  

• H. Litvan
  • 1
• E. Santacana
  • 1
• J. I. Casas
  • 1
• A. Aris
  • 1
• J. M. Villar Landeira
  • 1

1. 1.Hospital de la Santa Cruz y San Pablo School of MedicineUniversity of BarcelonaBarcelonaSpain

Correspondence

DOI: 10.1007/BF03009674

Cite this article as: 

Litvan, H., Santacana, E., Casas, J.I. et al. Can J Anaesth (1994) 41: 77. doi:10.1007/BF03009674

• 116Downloads

Download to read the full article text

References

1. 1.
   Trouwborst A, Haegenow RRPM, Jeekel J, Ong GL. Hypervolaemic haemodilution in an anaemic Jehovah’s Witness. Br J Anaesth 1990; 64: 646–8.PubMedCrossRefGoogle Scholar
2. 2.
   Gaudiani VA, Mason HDW. Preoperative erythropoietin in Jehovah’s Witnesses who require cardiac procedures. Ann Thorac Surg 1991; 51: 823–4.PubMedCrossRefGoogle Scholar
3. 3.
   Lichtenstein A, Eckhart WF, Swanson KJ, Vacanti CA, Zapol WM. Unplanned intraoperative and postoperative hemodilution: oxygen transport and consumption during severe anemia. Anesthesiology 1988; 69: 119–22.PubMedCrossRefGoogle Scholar
4. 4.
   Stone DJ, DiFazio CA. DDAVP to reduce blood loss in Jehovah’s Witnesses (Letter). Anesthesiology 1988; 69: 1028.PubMedCrossRefGoogle Scholar
5. 5.
   Bidstrup BP, Underwood SR, Sapfpord RN, Streets EM. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg 1993; 105: 147–53.PubMedGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1994

About this article

• Publisher NameSpringer-Verlag
•  
• Print ISSN0832-610X
•  
• Online ISSN1496-8975

• About this journal
• Reprints and Permissions

• 

  Co-published with

  Canadian Anesthesiologists' Society